Publications by authors named "Christopher Ambrose"

Claim this Profile
E
Effect of tezepelumab on asthma exacerbations co-occurring with infection-attributed acute respiratory illnesses.
Wojciech Feleszko, Marco Caminati, James E Gern, Sebastian L Johnston, Claudio Marchese, Christopher S Ambrose

Ann Allergy Asthma Immunol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asthma biologic effectiveness by age and sex in the US CHRONICLE study.
Alan P Baptist, Weily Soong, Bradley E Chipps, Njira Lugogo, Jennifer Trevor, Christopher S Ambrose

J Allergy Clin Immunol Glob· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologic outcomes in patients with severe asthma and clinically relevant allergy in the CHRONICLE study.
Bradley E Chipps, Warner W Carr, Reynold A Panettieri, Weily Soong, Jennifer Trevor, Christopher S Ambrose

J Allergy Clin Immunol Glob· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early and Sustained Improvements in Sense of Smell With Tezepelumab Treatment in Patients With Chronic Rhinosinusitis With Nasal Polyps (WAYPOINT).
Joaquim Mullol, Joseph K Han, Tanya M Laidlaw, Claire Hopkins, Anju T Peters, Christopher S Ambrose

Int Forum Allergy Rhinol· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes after biologic initiation among patients with severe asthma and normal lung function in the CHRONICLE study.
Reynold A Panettieri, Arjun Mohan, Njira L Lugogo, Dennis K Ledford, Donna D Carstens, Christopher S Ambrose

Respir Res· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Socioeconomic Disparities Explain Increased Exacerbations Among Black Patients With Severe Asthma.
Alan P Baptist, Wenjiong Zhou, Bradley E Chipps, Donna D Carstens, Christopher S Ambrose

J Allergy Clin Immunol Pract· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction to: Effectiveness and Safety of Tezepelumab in a Diverse Population of US Patients with Severe Asthma: Initial Results of the PASSAGE Study.
Njira L Lugogo, Praveen Akuthota, Kaharu Sumino, Sameer K Mathur, Autumn F Burnette, Christopher S Ambrose

Adv Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of tezepelumab in patients with severe, uncontrolled asthma and aspirin-exacerbated respiratory disease in NAVIGATOR.
Tanya M Laidlaw, Kathleen M Buchheit, Katherine N Cahill, Jonathan A Bernstein, Nicole L Martin, Christopher S Ambrose

J Allergy Clin Immunol Pract· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effectiveness and Safety of Tezepelumab in a Diverse Population of US Patients with Severe Asthma: Initial Results of the PASSAGE Study.
Njira L Lugogo, Praveen Akuthota, Kaharu Sumino, Sameer K Mathur, Autumn F Burnette, Christopher S Ambrose

Adv Ther· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Biologics in Reducing Exacerbations Requiring Hospitalization or an Emergency Department Visit in Patients with Moderate or Severe, Uncontrolled Asthma.
Reynold A Panettieri, Monica Kraft, Mario Castro, Magdalena Bober, Andrew W Lindsley, Christopher S Ambrose

Adv Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tezepelumab can Restore Normal Lung Function in Patients with Severe, Uncontrolled Asthma: Pooled Results from the PATHWAY and NAVIGATOR Studies.
Ian D Pavord, Christopher E Brightling, Stephanie Korn, Nicole L Martin, Sandhia S Ponnarambil, Christopher S Ambrose

Pulm Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world Outcomes Following Biologic Initiation in US Patients with Chronic Rhinosinusitis with Nasal Polyps.
Anju Peters, Xiaohui Zhao, Aimee M Near, Joseph Han, Joseph D Spahn, Christopher S Ambrose

Adv Ther· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On-treatment clinical remission of severe asthma with real-world longer-term biologic use.
Bradley E Chipps, Njira Lugogo, Warner Carr, Wenjiong Zhou, Arpan Patel, Christopher S Ambrose

J Allergy Clin Immunol Glob· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of Tezepelumab on Sino-Nasal Outcome Test (SNOT)-22 Domain and Symptom-Specific Scores in Patients with Severe, Uncontrolled Asthma and a History of Chronic Rhinosinusitis with Nasal Polyps.
Joshua S Jacobs, Joseph K Han, Jason K Lee, Tanya M Laidlaw, Nicole L Martin, Christopher S Ambrose

Adv Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient and clinician preferences for biologic treatments for severe uncontrolled asthma: a discrete choice experiment (DCE).
Melissa M Ross, Yen Chung, Tara Carr, Christopher S Ambrose, Andrew W Lindsley

J Asthma· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response and on-treatment clinical remission with tezepelumab in a broad population of patients with severe, uncontrolled asthma: results over 2 years from the NAVIGATOR and DESTINATION studies.
Michael E Wechsler, Guy Brusselle, J Christian Virchow, Arnaud Bourdin, Konstantinos Kostikas, Christopher S Ambrose

Eur Respir J· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral and inhaled corticosteroid dose reductions with tezepelumab versus placebo in patients with severe, uncontrolled asthma from DESTINATION.
Michael E Wechsler, Daiana Stolz, Njira L Lugogo, Scott Caveney, Gun Almqvist, Christopher S Ambrose

J Allergy Clin Immunol Pract· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of tezepelumab in patients with severe asthma and persistent airflow obstruction.
Elliot Israel, Mario Castro, Christopher S Ambrose, Jean-Pierre Llanos, Nestor A Molfino

ERJ Open Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biologic outcomes in U.S. Hispanic and Black patients with severe asthma.
Jennifer Trevor, Wendy C Moore, Njira Lugogo, Dennis K Ledford, Alexander Mackie, Christopher S Ambrose

J Allergy Clin Immunol Pract· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced Effectiveness of Anti-IgE Treatment Among Adults with Severe Asthma with Older Age of Asthma Onset: Results from the CHRONICLE Study.
Dennis K Ledford, Warner W Carr, Wendy C Moore, Njira L Lugogo, Arjun Mohan, Christopher S Ambrose

J Asthma Allergy· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gaps in Care Among Uncontrolled Severe Asthma Patients in the United States.
Tara Carr, Joseph Tkacz, Yen Chung, Christopher S Ambrose, Joseph Spahn

J Allergy Clin Immunol Pract· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma Across Multiple Clinically Relevant Subgroups in the NAVIGATOR Study.
Tara F Carr, Wendy C Moore, Monica Kraft, Guy Brusselle, Mario Castro, Christopher S Ambrose

Adv Ther· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Geographic variation in disease burden among patients with severe persistent asthma in the United States.
Carlos A Camargo, Pallavi B Rane, Andrew F Beck, Yan Wang, Yen Chung, Christopher S Ambrose

Ann Allergy Asthma Immunol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of Life Improvements with Biologic Initiation Among Subspecialist-Treated US Patients with Severe Asthma.
Weily Soong, Bradley E Chipps, Warner Carr, Jennifer Trevor, Arpan Patel, Christopher S Ambrose

J Asthma Allergy· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tezepelumab for Severe Asthma: One Drug Targeting Multiple Disease Pathways and Patient Types.
Reynold Panettieri, Njira Lugogo, Jonathan Corren, Christopher S Ambrose

J Asthma Allergy· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis